Susquehanna International Group, LLP Meridian Bioscience Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $1.32 Million - $1.43 Million	-42,700 Reduced 54.05%	36,300 $1.15 Million
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $358,625 - $478,519	-15,100 Reduced 16.05%	79,000 $2.4 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $93,859 - $126,618	-4,700 Reduced 4.76%	94,100 $2.44 Million
Q4 2021 Feb 14, 2022	BUY	$17.46 - $21.61 $368,406 - $455,971	21,100 Added 27.16%	98,800 $2.02 Million
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $513,560 - $666,000	-29,600 Reduced 27.59%	77,700 $1.5 Million
Q2 2021 Aug 11, 2021	SELL	$18.01 - $28.32 $1.09 Million - $1.72 Million	-60,600 Reduced 36.09%	107,300 $2.38 Million
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $1.67 Million - $2.52 Million	84,400 Added 101.08%	167,900 $4.41 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $559,988 - $771,096	35,600 Added 74.32%	83,500 $1.56 Million
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $50,098 - $97,717	-3,700 Reduced 7.17%	47,900 $813,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $322,224 - $957,219	41,100 Added 391.43%	51,600 $1.2 Million
Q1 2020 May 15, 2020	SELL	$5.57 - $11.5 $46,231 - $95,450	-8,300 Reduced 44.15%	10,500 $88,000
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $117,376 - $153,728	-12,800 Reduced 40.51%	18,800 $178,000
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $138,176 - $223,520	-12,700 Reduced 28.67%	31,600 $375,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $339,669 - $385,659	-21,900 Reduced 33.08%	44,300 $780,000
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $60,984 - $82,824	4,200 Added 6.77%	66,200 $1.15 Million
Q3 2018 Nov 14, 2018	SELL	$14.85 - $16.35 $513,810 - $565,710	-34,600 Reduced 35.82%	62,000 $924,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $691,380 - $841,680	50,100 Added 107.74%	96,600 $1.54 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $318,780 - $374,220	23,100 Added 98.72%	46,500 $660,000
Q4 2017 Feb 14, 2018	BUY	$13.55 - $15.8 $98,915 - $115,340	7,300 Added 45.34%	23,400 $328,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $216,545 - $231,035	16,100	16,100 $230,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account